6851 - 6900 of 7939 Results
Title
Year
-
OPENTitle: Higher Frequency of Certain Cancers inLRRK2G2019S Mutation Carriers With Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 1Start Page: 58End Page: 58Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1973Best OA location URL: https://europepmc.org/articles/pmc4366130?pdf=renderCitation Count: 86
- Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s Disease2014OPENTitle: Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s DiseaseJournal Name: Toxicological SciencesPublisher: Oxford University Press (OUP)Vol: 143Issue #: 2Start Page: 360End Page: 373Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/toxsci/kfu236Best OA location URL: https://academic.oup.com/toxsci/article-pdf/143/2/360/10915824/kfu236.pdfCitation Count: 43
-
OPENTitle: Clinical markers for identifying cholinergic deficits in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 269End Page: 273Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26061Best OA location URL: https://europepmc.org/articles/pmc4318774?pdf=renderCitation Count: 55
-
OPENTitle: The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD studyJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 2Start Page: 278End Page: 283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26065Best OA location URL: https://europepmc.org/articles/pmc4318772?pdf=renderCitation Count: 16
-
RESTRICTEDTitle: Microglial and macrophage polarization—new prospects for brain repairJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 56End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2014.207Best OA location URL: https://europepmc.org/articles/pmc4395497?pdf=renderCitation Count: 1040
- MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a2014OPENTitle: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320aJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 278Issue #:Start Page: 185End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004Best OA location URL: https://europepmc.org/articles/pmc4297694?pdf=renderCitation Count: 61
-
RESTRICTEDTitle: Neuroimaging biomarkers for Parkinson disease: Facts and fantasyJournal Name: Annals of NeurologyPublisher: WileyVol: 76Issue #: 6Start Page: 769End Page: 783Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24291Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.24291Citation Count: 39
- Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase Parkin2014OPENTitle: Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase ParkinJournal Name: PLoS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 10Issue #: 11Start Page: e1003935End Page: e1003935Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1003935Best OA location URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1003935&type=printableCitation Count: 105
-
OPENTitle: Analysis of COQ2gene in multiple system atrophyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1750-1326-9-44Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/1750-1326-9-44Citation Count: 44
- Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic Calcium Signaling in Astrocytes2014OPENTitle: Dopaminergic Neurotoxicants Cause Biphasic Inhibition of Purinergic Calcium Signaling in AstrocytesJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 11Start Page: e110996End Page: e110996Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0110996Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0110996&type=printableCitation Count: 11
- Latent growth-curve analysis reveals that worsening Parkinson’s disease quality of life is driven by depression.2014OPENTitle: Latent growth-curve analysis reveals that worsening Parkinson’s disease quality of life is driven by depression.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 29Issue #: 4Start Page: 603End Page: 609Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1037/neu0000158Best OA location URL: https://europepmc.org/articles/pmc5036570?pdf=renderCitation Count: 19
-
RESTRICTEDTitle: Antibodies and protein misfolding: From structural research tools to therapeutic strategiesJournal Name: Biochimica et Biophysica Acta (BBA) - Proteins and ProteomicsPublisher: Elsevier BVVol: 1844Issue #: 11Start Page: 1907End Page: 1919Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.bbapap.2014.08.016Best OA location URL: https://doi.org/10.1016/j.bbapap.2014.08.016Citation Count: 58
- Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging2014OPENTitle: Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimagingJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 6Start Page: 779End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2014.09.001Best OA location URL: https://europepmc.org/articles/pmc4273919?pdf=renderCitation Count: 27
-
RESTRICTEDTitle: Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS DrugsJournal Name: NeuronPublisher: Elsevier BVVol: 84Issue #: 3Start Page: 554End Page: 563Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2014.10.027Best OA location URL: http://www.cell.com/article/S0896627314009477/pdfCitation Count: 64
-
RESTRICTEDTitle: The Future of Research in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 11Start Page: 1351End Page: 1351Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1717Citation Count: 31
- Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study2014OPENTitle: Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1097End Page: 1104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.10.029Best OA location URL: https://europepmc.org/articles/pmc4315708?pdf=renderCitation Count: 137
-
OPENTitle: LRRK2 Transport Is Regulated by Its Novel Interacting Partner Rab32Journal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 10Start Page: e111632End Page: e111632Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0111632Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0111632&type=printableCitation Count: 87
-
RESTRICTEDTitle: Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 24Issue #: 24Start Page: 5648End Page: 5651Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2014.10.079Citation Count: 8
- Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits2014OPENTitle: Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficitsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 74Issue #:Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.016Best OA location URL: https://europepmc.org/articles/pmc4505366?pdf=renderCitation Count: 138
-
OPENTitle: Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson DiseaseJournal Name: NeuronPublisher: Elsevier BVVol: 84Issue #: 4Start Page: 716End Page: 722Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2014.08.061Best OA location URL: http://www.cell.com/article/S0896627314008964/pdfCitation Count: 102
- Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology2014OPENTitle: Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12104Citation Count: 2
- Role for NUP62 depletion and PYK2 redistribution in dendritic retraction resulting from chronic stress2014OPENTitle: Role for NUP62 depletion and PYK2 redistribution in dendritic retraction resulting from chronic stressJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 45Start Page: 16130End Page: 16135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1418896111Best OA location URL: https://www.pnas.org/content/pnas/111/45/16130.full.pdfCitation Count: 46
- Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled Trial2014OPENTitle: Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled TrialJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 348End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12082Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12082Citation Count: 11
-
RESTRICTEDTitle: Current Challenges Towards the Development of a Blood Test for Parkinson’s DiseaseJournal Name: DiagnosticsPublisher: MDPI AGVol: 4Issue #: 4Start Page: 153End Page: 164Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics4040153Best OA location URL: https://www.mdpi.com/2075-4418/4/4/153/pdf?version=1413988424Citation Count: 9
- Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease2014OPENTitle: Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00249Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00249/pdfCitation Count: 76
-
RESTRICTEDTitle: Striatal cholinergic interneuron regulation and circuit effectsJournal Name: Frontiers in Synaptic NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsyn.2014.00022Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnsyn.2014.00022/pdfCitation Count: 176
-
OPENTitle: Mind matters: placebo enhances reward learning in Parkinson's diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 17Issue #: 12Start Page: 1793End Page: 1797Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3842Best OA location URL: https://europepmc.org/articles/pmc4503317?pdf=renderCitation Count: 78
- New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's disease2014OPENTitle: New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's diseaseJournal Name: Neurogastroenterology & MotilityPublisher: WileyVol: 26Issue #: 12Start Page: 1771End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nmo.12459Best OA location URL: https://europepmc.org/articles/pmc4457321?pdf=renderCitation Count: 49
- α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)2014RESTRICTEDTitle: α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 73Issue #:Start Page: 229End Page: 243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.007Citation Count: 34
-
OPENTitle: Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 10Start Page: e108982End Page: e108982Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0108982Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0108982&type=printableCitation Count: 76
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease2014OPENTitle: Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1394End Page: 1398Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.10.008Best OA location URL: https://europepmc.org/articles/pmc4314515?pdf=renderCitation Count: 84
-
OPENTitle: Sensitive measures of executive dysfunction in non-demented Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1430End Page: 1433Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.10.007Best OA location URL: https://escholarship.org/content/qt32g6f0vn/qt32g6f0vn.pdf?t=rt4g05Citation Count: 15
- Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis2014OPENTitle: Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosisJournal Name: European Journal of NeurologyPublisher: WileyVol: 22Issue #: 2Start Page: 328End Page: 333Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.12572Best OA location URL: https://europepmc.org/articles/pmc4289423?pdf=renderCitation Count: 46
- Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome2014OPENTitle: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteomeJournal Name: PROTEOMICSPublisher: WileyVol: 15Issue #: 2-3Start Page: 500End Page: 507Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201400171Best OA location URL: https://europepmc.org/articles/pmc4598062?pdf=renderCitation Count: 48
-
RESTRICTEDTitle: What matters to people with Parkinson’s disease living in Australia?Journal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 22Issue #: 2Start Page: 338End Page: 341Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2014.06.097Citation Count: 9
-
OPENTitle: Imaging prodromal Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 83Issue #: 19Start Page: 1739End Page: 1746Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000960Best OA location URL: https://europepmc.org/articles/pmc4239830?pdf=renderCitation Count: 145
- Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microglia2014OPENTitle: Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microgliaJournal Name: NeurosciencePublisher: Elsevier BVVol: 302Issue #:Start Page: 121End Page: 137Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.052Best OA location URL: https://europepmc.org/articles/pmc4385752?pdf=renderCitation Count: 48
-
OPENTitle: Treatment of myoclonus-dystonia syndrome with tetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 1423End Page: 1426Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.029Best OA location URL: https://europepmc.org/articles/pmc4254189?pdf=renderCitation Count: 31
- AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo2014RESTRICTEDTitle: AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivoJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 73Issue #:Start Page: 150End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.09.013Citation Count: 62
- Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex2014OPENTitle: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 571End Page: 582Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023Best OA location URL: https://europepmc.org/articles/pmc4315751?pdf=renderCitation Count: 80
- Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis2014OPENTitle: Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axisJournal Name: American Journal of Physiology-Gastrointestinal and Liver PhysiologyPublisher: American Physiological SocietyVol: 307Issue #: 10Start Page: G1013End Page: G1023Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/ajpgi.00258.2014Best OA location URL: https://europepmc.org/articles/pmc4865236Citation Count: 47
-
OPENTitle: Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 10Start Page: e109042End Page: e109042Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0109042Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0109042&type=printableCitation Count: 30
-
OPENTitle: Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s diseaseJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 9Issue #: 3Start Page: 619End Page: 638Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11682-014-9317-9Best OA location URL: https://europepmc.org/articles/pmc4385510?pdf=renderCitation Count: 31
-
OPENTitle: Highlights of the Stockholm Congress: A Clinician's PerspectiveJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 277End Page: 279Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12093Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12093Citation Count: 0
-
RESTRICTEDTitle: Novel insights into the neurobiology underlying LRRK2-linked Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 85Issue #:Start Page: 45End Page: 56Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2014.05.020Citation Count: 21
-
RESTRICTEDTitle: The Nuclear Envelope: An Intriguing Focal Point for Neurogenetic DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 764End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0296-8Best OA location URL: https://europepmc.org/articles/pmc4391386?pdf=renderCitation Count: 17
- Hybrid Bayesian-rank integration approach improves the predictive power of genomic dataset aggregation2014OPENTitle: Hybrid Bayesian-rank integration approach improves the predictive power of genomic dataset aggregationJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 2Start Page: 209End Page: 215Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btu518Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/31/2/209/17125420/btu518.pdfCitation Count: 17
- Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases2014OPENTitle: Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseasesJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 41Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1405003111Best OA location URL: https://www.pnas.org/content/pnas/111/41/E4367.full.pdfCitation Count: 529
-
RESTRICTEDTitle: The Role of microRNAs in Mitochondria: Small Players Acting WideJournal Name: GenesPublisher: MDPI AGVol: 5Issue #: 4Start Page: 865End Page: 886Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes5040865Best OA location URL: https://www.mdpi.com/2073-4425/5/4/865/pdf?version=1411736411Citation Count: 116
- Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers2014OPENTitle: Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriersJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00248Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00248/pdfCitation Count: 62